A video on how Kids v Cancer is creating incentives and requirements for companies to undertake pediatric studies. more→
(KVC Publication) RACE for Children Act Thank You Book Volume 3
Download the RACE for Children Act Thank You Book, Vol. 3 Or cut and paste this URL: https://www.kidsvcancer.org/wp-content/uploads/2018/01/Thank-you-book-2017-single-page.pdf
(The Cancer Letter) How the RACE for Children Act Will Get Drugs to Kids with Cancer, Nancy Goodman)
Taken together, the RACE for Children Act and the Pediatric PRV program change the landscape of pediatric cancer research. more→
(RAPS Regulatory Explainer) Everything you need to know about FDA’s Priority Review Vouchers
What are the Priority Review Vouchers and how do they benefit the society? more→
(Science) Children with cancer get more access to experimental drugs
The Research to Accelerate Cures and Equity for Children (RACE) Act will close loopholes in U.S. drug approval guidelines that companies have exploited to avoid enrolling children in clinical cancer research. more→
(Morning Consult) Don’t leave them waiting: How to bring new cancer drugs to kids, by Elena Gerasimov)
The RACE Act is needed because most kids with cancer are treated with medicines from the time when my mom was young. more→
(Life Science Daily) RACE for Children Act seeks to boost childhood cancer research
Current law does not reflect advances in cancer drug development because these therapies have been under-studied in pediatric cancer. more→
(CNBC-video) Kids v. Cancer advocates for RACE for Children Act
Nancy Goodman, Kids v. Cancer founder, discusses her push for the development of pediatric cancer drugs. With CNBC’s Meg Tirrell.
(Blog) Creating Hope Act reauthorized in 21st Century Cures
On December 13, 2016, President Obama signed into law the 21st Century Cures Act, reauthorizing the Creating Hope Act until 2020. more→
(Fast Company) Kids v Cancer a 10 most innovative not-for-profits for 2016
https://www.fastcompany.com/most-innovative-companies/2016/sectors/not-for-profit
(The Cancer Letter) Too many PD-1 trials for adults, too few for children, Nancy Goodman
Why are there so few trials for which children and young teens would qualify? Shouldn’t kids and teens also get a shot at exciting investigational drugs? more→
(PBS News Hour) How one drug company fast-tracked the FDA’s review process
A voucher program shaves months off of the FDA’s review process for drug development that targets rare pediatric diseases. more→
Nature supports RACE for Children Act
Kids v Cancer welcomes NATURE’s editorial in support of the RACE for Children Act to champion the development of promising cancer drugs for children. more→
(Nature Magazine) Fairer way to distribute last-ditch drugs gets real-world trial (Nature Magazine)
Drug companies’ compassionate policies hard to decipher, and experts are testing what they hope is a fairer system to distribute drugs. more→
(Blog) KVC launches the Compassionate Use Navigator
We are proud to announce the launch of the Compassionate Use Navigator, a new service that provides assistance getting access to drugs on a compassionate use basis. more→